NextCure Inc (NXTC)
1.55
-0.06
(-3.73%)
USD |
NASDAQ |
May 24, 16:00
1.53
-0.02
(-1.29%)
After-Hours: 20:00
NextCure Price to Book Value: 0.4378 for May 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 24, 2024 | 0.4378 |
May 23, 2024 | 0.4547 |
May 22, 2024 | 0.4575 |
May 21, 2024 | 0.4716 |
May 20, 2024 | 0.4603 |
May 17, 2024 | 0.4716 |
May 16, 2024 | 0.466 |
May 15, 2024 | 0.4688 |
May 14, 2024 | 0.4491 |
May 13, 2024 | 0.4519 |
May 10, 2024 | 0.466 |
May 09, 2024 | 0.4858 |
May 08, 2024 | 0.4462 |
May 07, 2024 | 0.4462 |
May 06, 2024 | 0.466 |
May 03, 2024 | 0.4321 |
May 02, 2024 | 0.4208 |
May 01, 2024 | 0.3869 |
April 30, 2024 | 0.3417 |
April 29, 2024 | 0.3304 |
April 26, 2024 | 0.3813 |
April 25, 2024 | 0.3643 |
April 24, 2024 | 0.4067 |
April 23, 2024 | 0.431 |
April 22, 2024 | 0.4536 |
Date | Value |
---|---|
April 19, 2024 | 0.4507 |
April 18, 2024 | 0.4423 |
April 17, 2024 | 0.4254 |
April 16, 2024 | 0.462 |
April 15, 2024 | 0.4705 |
April 12, 2024 | 0.5409 |
April 11, 2024 | 0.5296 |
April 10, 2024 | 0.5324 |
April 09, 2024 | 0.5324 |
April 08, 2024 | 0.5775 |
April 05, 2024 | 0.6141 |
April 04, 2024 | 0.6085 |
April 03, 2024 | 0.6761 |
April 02, 2024 | 0.7015 |
April 01, 2024 | 0.6508 |
March 28, 2024 | 0.5438 |
March 27, 2024 | 0.4719 |
March 26, 2024 | 0.4804 |
March 25, 2024 | 0.4853 |
March 22, 2024 | 0.4633 |
March 21, 2024 | 0.4097 |
March 20, 2024 | 0.3438 |
March 19, 2024 | 0.3487 |
March 18, 2024 | 0.3512 |
March 15, 2024 | 0.3536 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1836
Minimum
Dec 22 2022
12.29
Maximum
Nov 05 2019
1.291
Average
0.6878
Median
Nov 15 2021
Price to Book Value Benchmarks
Assertio Holdings Inc | 0.7073 |
DiaMedica Therapeutics Inc | 2.359 |
Terns Pharmaceuticals Inc | 1.639 |
NovaBay Pharmaceuticals Inc | -- |
Palatin Technologies Inc | 20.44 |
Price to Book Value Related Metrics
PS Ratio | 1.578 |
Price | 1.55 |
Earnings Yield | -147.1% |
Market Cap | 43.36M |